PARP10 Mediates Mono-ADP-Ribosylation of Aurora-A Regulating G2/M Transition of the Cell Cycle
Overview
Authors
Affiliations
Intracellular mono-ADP-ribosyltransferases (mono-ARTs) catalyze the covalent attachment of a single ADP-ribose molecule to protein substrates, thus regulating their functions. PARP10 is a soluble mono-ART involved in the modulation of intracellular signaling, metabolism and apoptosis. PARP10 also participates in the regulation of the G1- and S-phase of the cell cycle. However, the role of this enzyme in G2/M progression is not defined. In this study, we found that genetic ablation, protein depletion and pharmacological inhibition of PARP10 cause a delay in the G2/M transition of the cell cycle. Moreover, we found that the mitotic kinase Aurora-A, a previously identified PARP10 substrate, is actively mono-ADP-ribosylated (MARylated) during G2/M transition in a PARP10-dependent manner. Notably, we showed that PARP10-mediated MARylation of Aurora-A enhances the activity of the kinase in vitro. Consistent with an impairment in the endogenous activity of Aurora-A, cells lacking PARP10 show a decreased localization of the kinase on the centrosomes and mitotic spindle during G2/M progression. Taken together, our data provide the first evidence of a direct role played by PARP10 in the progression of G2 and mitosis, an event that is strictly correlated to the endogenous MARylation of Aurora-A, thus proposing a novel mechanism for the modulation of Aurora-A kinase activity.
Morone B, Grimaldi G Expert Rev Mol Med. 2024; 26:e17.
PMID: 39189367 PMC: 11440612. DOI: 10.1017/erm.2024.13.
Pathological and physiological roles of ADP-ribosylation: established functions and new insights.
Feijs-Zaja K, Ikenga N, Zaja R Biol Chem. 2024; .
PMID: 39066732 DOI: 10.1515/hsz-2024-0057.
Wu H, Lu A, Yuan J, Yu Y, Lv C, Lu J Cell Death Discov. 2024; 10(1):226.
PMID: 38734665 PMC: 11088682. DOI: 10.1038/s41420-024-01994-5.
ADP-ribosylation from molecular mechanisms to therapeutic implications.
Suskiewicz M, Prokhorova E, Rack J, Ahel I Cell. 2023; 186(21):4475-4495.
PMID: 37832523 PMC: 10789625. DOI: 10.1016/j.cell.2023.08.030.
Privileged Scaffolds for Potent and Specific Inhibitors of Mono-ADP-Ribosylating PARPs.
Nizi M, Sarnari C, Tabarrini O Molecules. 2023; 28(15).
PMID: 37570820 PMC: 10420676. DOI: 10.3390/molecules28155849.